泰國首位世界小姐冠軍誕生 22歲女積極推動防治乳癌(有片)
綜合報道，身高180公分的Chuangsri來自普吉府，精通中英泰三語，立志成為外交官。她推廣「Opal for Her」乳癌倡議組織計畫逾3年，盼藉世界小姐平台將其擴展至全球。結果Chuangsri在108位參賽者中脫穎而出，由去年冠軍捷克小姐Krystyna Pyszková為她加冕。她在賽後表示，這不僅是個人勝利，更是每個渴望改變的年輕女孩的共同夢想，她將利用此身份做出真正改變。
比賽中，Chuangsri憑藉「亞洲及大洋洲多媒體挑戰賽」冠軍直入40強。在關鍵問答環節，她以照料花園比喻代表角色，並強調以善良和行動領導的重要性，最終贏得評審青睞。世界小姐組織主席Julia Morley讚揚Chuangsri是位有目標的女性，世界已準備好聆聽她的聲音。衣索比亞小姐Hasset Dereje Admassu獲亞軍，波蘭的Maja Klajda獲季軍，來自法國海外大區Martinique的Aurelie Joachim則獲得殿軍。
Warm congratulations💐to @Opalsuchaaata (Opal Suchata Chuangsri ) from Thailand for winning the 72nd Miss World competition, hosted with pride in Telangana, India.Her grace, intelligence, and purpose have inspired millions around the globe. This prestigious victory not only… pic.twitter.com/42TmVOAXMZ
— Ponguleti Srinivasa Reddy (@INC_Ponguleti) May 31, 2025
原文刊登於 AM730 https://www.am730.com.hk/國際/泰國首位世界小姐冠軍誕生-22歲女積極推動防治乳癌-有片-/566117?utm_source=yahoorss&utm_medium=referral
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
an hour ago
- Business Upturn
The Root Brands Achieves Major Milestone, ranked #1922 on Prestigious Inc. 5000 List of America's Fastest-Growing Private Companies
Franklin, TN, Aug. 13, 2025 (GLOBE NEWSWIRE) — The Root Brands, a breakthrough health and wellness company, achieved #1922 on the prestigious 2025 Inc. 5000 list of America's fastest-growing private companies. This elite recognition validates explosive revenue growth from $3 million to $61 million over four years, powered by patented nanotechnology detox solutions and innovative wellness products. 'This Inc. 5000 recognition validates our mission to revolutionize global health through natural detoxification and cutting-edge wellness solutions,' said Clayton Thomas, Founder and CEO. 'We're transforming lives worldwide by making premium health products accessible to everyone, everywhere.' Breakthrough Patented Technology Drives Market Disruption The Root Brands' meteoric rise stems from Dr. Christina Rahm's revolutionary patented formulations, including breakthrough water-soluble clinoptilolite technology for advanced detoxification. With 18 patent-pending innovations and 6 approved patents, Dr. Rahm's proprietary nanotechnology has created industry-leading wellness supplements that deliver measurable health results. The Trinity® Products – the company's flagship three-product system featuring Clean Slate®, Zero-In®, and Restore® – work synergistically to deliver comprehensive wellness results. This powerful trinity performs complete detoxification, mental clarity enhancement, and cellular restoration, creating the foundation for optimal health. This groundbreaking three-step approach has captured 220,000+ loyal customers across 90+ countries seeking effective holistic wellness solutions. 'Cure the Causes®' – Registered Healthcare Revolution Dr. Rahm's 'Cure the Causes®' philosophy, officially trademarked in July 2025, represents a paradigm shift from symptom treatment to root cause healing. This holistic healthcare approach has been translated into 27 languages, creating a global wellness movement that drives customer loyalty and organic growth. Power Partnership Fuels Success The dynamic partnership between CEO Clayton Thomas and his wife, Dr. Christina Rahm (Chief Science Officer), has pushed The Root Brands to unprecedented success. Their combined expertise in business strategy and scientific innovation creates a competitive advantage that competitors cannot replicate. Franklin Corporate Excellence The Root Brands' corporate headquarters in Franklin, Tennessee, drives continuous innovation across products, staff development, and global operations. This dedicated team ensures consistent delivery of premium wellness solutions to customers worldwide. Ambassador-Driven Marketing Success Unlike traditional advertising, The Root Brands achieves explosive growth through authentic customer testimonials and ambassador advocacy. Real success stories from satisfied customers create powerful word-of-mouth marketing that builds trust and drives organic expansion across global markets. The ROOT Prime subscription program ensures consistent product delivery while customer success stories fuel sustainable growth, creating a self-perpetuating business model that continues expanding internationally. About The Root Brands Founded in 2020 in Franklin, Tennessee, The Root Brands develops premium natural health supplements, detox products, and wellness solutions using patented nanotechnology. The company's 'Cure the Causes®' methodology focuses on root cause healing through advanced detoxification, serving customers in 90+ countries with organic, non-GMO, vegan, and gluten-free formulations. Core Products: The Trinity System (Clean Slate, Zero-In, Restore), Natural Barrier Support (immunity), Relive Greens (nutrition) Key Metrics: 220,000+ customers | 90+ countries | 20x growth since 2020 About Inc. 5000 The Inc. 5000 ranks America's fastest-growing private companies based on percentage revenue growth from 2021-2024, requiring minimum revenues of $100,000 (2021) and $2 million (2024). Past honorees include Microsoft, Facebook, Under Armor, and Chobani. Media Contact: Marty McGinley – VP MarketingThe Root BrandsPhone: (980) 400-3245 Email: [email protected] Address: 393 Nichol Mill Lane, Unit 250B, Franklin, TN 37067 Website:
Indianapolis Star
5 hours ago
- Indianapolis Star
Jaguar Health to Hold Investor Webcast Thursday, August 14 at 8:30 AM Eastern Regarding Q2 2025 Financials & Corporate Updates
Click here to register Jaguar CEO Lisa Conte presenting August 20 at Emerging Growth Conference to provide updates on near-term catalysts; Click here to register SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / August 12, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the company will conduct an investor webcast on Thursday, August 14, 2025, at 8:30 a.m. Eastern to review second-quarter 2025 financials and provide corporate updates. Participation Instructions for Jaguar Investor Webcast When: Thursday, August 14, 2025 at 8:30 AM Eastern Time Participant Registration & Access Link: Click Here Participation Instructions for Jaguar's Virtual Presentation at the Emerging Growth Conference When: Wednesday, August 20, 2025 from 2:55 – 3:05 PM Eastern Time Where: Online (Click Here) Registration link for conference: Click Here Replay: An archived webcast of the presentation will be made available on and on the Emerging Growth YouTube Channel. About the Jaguar Health Family of Companies Jaguar Health, Inc. (Jaguar) is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, bowel incontinence, and cramping pain. Jaguar family company Napo Pharmaceuticals (Napo) focuses on developing and commercializing human prescription pharmaceuticals for essential supportive care and management of neglected gastrointestinal symptoms across multiple complicated disease states. Napo's crofelemer is FDA-approved under the brand name Mytesi ® for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. Jaguar family company Napo Therapeutics is an Italian corporation Jaguar established in Milan, Italy in 2021 focused on expanding crofelemer access in Europe and specifically for orphan diseases. Jaguar Animal Health is a Jaguar tradename. Magdalena Biosciences, a joint venture formed by Jaguar and Filament Health Corp. that emerged from Jaguar's Entheogen Therapeutics Initiative (ETI), is focused on developing novel prescription medicines derived from plants for mental health indications. For more information about: Jaguar Health, visit Napo Pharmaceuticals, visit Napo Therapeutics, visit Magdalena Biosciences, visit Canalevia-CA1, visit Visit the Make Cancer Less Shitty patient advocacy program on Bluesky, X, Facebook & Instagram Forward-Looking Statements Certain statements in this press release constitute 'forward-looking statements.' These include statements regarding the expectation that Jaguar will file its 10-Q on August 14, 2025 for the quarter ended June 30, 2025, the expectation that Jaguar will hold an investor webcast on August 14, 2025, and Jaguar's expectation that Jaguar management will present at the August 2025 Emerging Growth Conference. In some cases, you can identify forward-looking statements by terms such as 'may,' 'will,' 'should,' 'expect,' 'plan,' 'aim,' 'anticipate,' 'could,' 'intend,' 'target,' 'project,' 'contemplate,' 'believe,' 'estimate,' 'predict,' 'potential' or 'continue' or the negative of these terms or other similar expressions. The forward-looking statements in this release are only predictions. Jaguar has based these forward-looking statements largely on its current expectations and projections about future events. These forward-looking statements speak only as of the date of this release and are subject to a number of risks, uncertainties and assumptions, some of which cannot be predicted or quantified and some of which are beyond Jaguar's control. Except as required by applicable law, Jaguar does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise. Contact: hello@ Jaguar-JAGX SOURCE: Jaguar Health, Inc.
Yahoo
5 hours ago
- Yahoo
Trump's Deal With Nvidia Offers Path Forward in Global Trade War
(Bloomberg) -- President Donald Trump's controversial plan to take a cut of revenue from chip sales to China has US companies reconsidering their plans for business with the country, offering a model for circumventing years of trade tensions. Experts and people familiar with the matter said the surprise deal, in which Nvidia Corp. and Advanced Micro Devices Inc. agreed to pay 15% of their revenues from Chinese AI chip sales to the US, provides a path to enter the Chinese market despite severe export controls, tariffs and other trade barriers. Sunseeking Germans Face Swiss Backlash Over Alpine Holiday Congestion The US-Canadian Road Safety Gap Is Getting Wider To Head Off Severe Storm Surges, Nova Scotia Invests in 'Living Shorelines' Five Years After Black Lives Matter, Brussels' Colonial Statues Remain For Homeless Cyclists, Bikes Bring an Escape From the Streets The question that companies must now confront is whether the risk is worth taking. People familiar with the matter, who asked not to be identified discussing private deliberations, said companies are struggling to figure out what the president's order means for their future, especially given the unpredictable nature of Trump's decision-making. 'This is truly bizarre and unusual, and the troubling thing — beyond the individual instances of AMD and Nvidia — is the possibility that this will be expanded,' said Gary Hufbauer, a senior fellow at the Peterson Institute for International Economics. 'Everything is now 'national security,' according to the new definition, which means it's all subject to export licenses and then they give you a license based on your contribution.' There are concerns that US trade agencies could begin charging fees to companies every time there's a meeting to discuss tariffs, according to people familiar with the matter who asked not to be identified discussing private deliberations. Trump administration officials defend the idea as a smart way to generate revenue for the US government and suggest it will extend well beyond the chips sector. 'I think we could see it in other industries over time,' Treasury Secretary Scott Bessent said in an interview with Bloomberg Television on Wednesday. 'I think right now this is unique, but now that we have the model and the beta tests, why not expand it?' Bessent defended the deal and rejected any national-security concerns around the decision to sell Nvidia's H20 chip to China — something that had been earlier barred for fear of giving China a boost in the artificial-intelligence race. 'There are no national security concerns here,' Bessent said. 'We would not sell any of the advanced chips. So, the H20, I don't know whether you'd say they're four, five, six levels down the chips stack.' Either way, the deal highlights how Trump has pushed to open a wave of new revenue streams including by taking ownership shares of companies or extracting higher fees to live or work in the US. The US is weighing sales of a so-called 'gold card' residency permit, it won a 'golden share' to have direct say over corporate actions by United States Steel Corp., and it's secured investment pledges and potential revenue-sharing in country-level tariff talks. That's aside from the barrage of product tariffs that have at times left massive dislocations in globally traded markets. The matter further surprised China hawks in Congress, who have been unimpressed by the administration's reassurances. Rep. John Moolenaar, the Michigan Republican who chairs the US House Select Committee on China, questioned the legal basis for the move and suggested it does an end-run around controls put in place to limit the sale of sensitive technology to US adversaries. 'Export controls are a front-line defense in protecting our national security, and we should not set a precedent that incentivizes the government to grant licenses to sell China technology that will enhance its AI capabilities,' he said. It also raises questions about where the administration will steer the revenue. Trump has mused about issuing tariff rebate checks — though he has yet to seriously pursue the idea — while at other times he's said it would go toward narrowing the large budget deficit. The administration had debated launching a sovereign wealth fund before shelving those plans for now. It's too soon to say whether the administration will seek to revive the fund and steer revenue there, one official familiar with deliberations said. 'Trump's aides argue that these measures will strengthen America's AI leadership by maximizing its global influence and market share,' Hal Brands, a professor at the Johns Hopkins School of Advanced International Studies and a former Pentagon official, wrote in Bloomberg Opinion. 'Yet it is also possible that they will simply eat into America's innovation advantage.' --With assistance from Mackenzie Hawkins. Americans Are Getting Priced Out of Homeownership at Record Rates Dubai's Housing Boom Is Stoking Fears of Another Crash Bessent on Tariffs, Deficits and Embracing Trump's Economic Plan Why It's Actually a Good Time to Buy a House, According to a Zillow Economist The Social Media Trend Machine Is Spitting Out Weirder and Weirder Results ©2025 Bloomberg L.P. Sign in to access your portfolio
